- Report
- June 2026
- 305 Pages
Global
From €3815EUR$4,150USD£3,243GBP
- Report
- March 2026
- 320 Pages
Global
From €3815EUR$4,150USD£3,243GBP
- Report
- April 2026
- 152 Pages
Global
From €4274EUR$4,650USD£3,634GBP
- Report
- December 2025
- 166 Pages
Global
From €4274EUR$4,650USD£3,634GBP
- Report
- June 2026
- 200 Pages
Global
From €2749EUR$2,990USD£2,337GBP
- Report
- February 2026
- 150 Pages
Global
From €5469EUR$5,950USD£4,650GBP
- Report
- May 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,509GBP
- Report
- December 2025
- 200 Pages
Global
From €2289EUR$2,490USD£1,946GBP
- Report
- January 2026
Global
From €4504EUR$4,900USD£3,830GBP
- Report
- September 2026
- 187 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- January 2026
- 199 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 189 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 185 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 188 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 193 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 181 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 196 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 184 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 198 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 189 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more